After Hours Decliner
SION Sionna Therapeutics8.26+0.41+5.2%
After Hours:8.00-0.26 (-3.2%)
Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
Globe NewswireMon, 14-Sep 4:01 PM
SION Sionna Therapeutics6.22+1.12 (+22.0%)
SION Sionna Therapeutics5.31+0.81 (+18.0%)
SION Sionna Therapeutics4.05-46.99 (-92.1%)
Premarket Decliner
SION Sionna Therapeutics51.04+1.43+2.9%
Premarket:6.82-44.22 (-86.6%)
Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
Globe NewswireMon, 10-Aug 7:00 AM